Inventor
WILSON BRYAN R
US25 patents
⚠️ This page may combine multiple inventors who share the name “WILSON BRYAN R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MANNKIND CORP
16 patentsUS7820676B2Oct 26, 2010
Diketopiperazine salts for drug delivery and related methods
MANNKIND CORP81 citations99
US8039431B2Oct 18, 2011
Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
MANNKIND CORP58 citations97
US10130685B2Nov 20, 2018
Diketopiperazine salts for drug delivery and related methods
MANNKIND CORP8 citations92
US9259471B2Feb 16, 2016
Diketopiperazine salts for drug delivery and related methods
MANNKIND CORP8 citations92
US7833550B2Nov 16, 2010
Dry powder formulations of antihistamine for nasal administration
MANNKIND CORP40 citations92
US7833549B2Nov 16, 2010
Dry powder formulations of antihistamine for nasal administration
MANNKIND CORP39 citations92
US9675674B2Jun 13, 2017
Diketopiperazine salts for drug delivery and related methods
MANNKIND CORP4 citations84
US10912821B2Feb 9, 2021
Diketopiperazine salts for drug delivery and related methods
MANNKIND CORP2 citations73
US10583176B2Mar 10, 2020
Diketopiperazine salts for drug delivery and related methods
MANNKIND CORP2 citations73
US10421729B2Sep 24, 2019
Microcrystalline diketopiperazine compositions and methods
MANNKIND CORP3 citations72
US11872265B2Jan 16, 2024
Diketopiperazine salts for drug delivery and related methods
MANNKIND CORP0 citations62
US11192862B2Dec 7, 2021
Microcrystalline diketopiperazine compositions and methods
MANNKIND CORP0 citations62
US10130581B2Nov 20, 2018
Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
MANNKIND CORP1 citations62
US9241903B2Jan 26, 2016
Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
MANNKIND CORP2 citations62
US10745359B2Aug 18, 2020
Microcrystalline diketopiperazine compositions and methods
MANNKIND CORP0 citations51
US10376466B2Aug 13, 2019
Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
MANNKIND CORP0 citations51
CARA THERAPEUTICS INC
3 patentsUS11033629B2Jun 15, 2021
Oral formulations of kappa opioid receptor agonists
CARA THERAPEUTICS INC4 citations73
US11986509B2May 21, 2024
Oligosaccharide formulations of kappa opioid receptor agonists
CARA THERAPEUTICS INC0 citations62
US11684674B2Jun 27, 2023
Oral formulations of kappa opioid receptor agonists
CARA THERAPEUTICS INC1 citations62
LEONE-BAY ANDREA
2 patentsBIODEL INC
2 patentsUS9381247B2Jul 5, 2016
Magnesium compositions for modulating the pharmacokinetics and pharmacodynamics of insulin and insulin analogs, and injection site pain
BIODEL INC6 citations72
US9399065B2Jul 26, 2016
Magnesium compositions for modulating the pharmacokinetics and injection site pain of insulin
BIODEL INC3 citations69